Cargando…
mTOR, a Potential Target to Treat Autism Spectrum Disorder
Mammalian target of rapamycin (mTOR) is a key regulator in various cellular processes, including cell growth, gene expression, and synaptic functions. Autism spectrum disorder (ASD) is frequently accompanied by monogenic disorders, such as tuberous sclerosis complex, phosphatase and tensin homolog t...
Autor principal: | Sato, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070418/ https://www.ncbi.nlm.nih.gov/pubmed/27071790 http://dx.doi.org/10.2174/1871527315666160413120638 |
Ejemplares similares
-
Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
por: Onore, Charity, et al.
Publicado: (2017) -
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
por: Thomas, Shilu Deepa, et al.
Publicado: (2023) -
mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity
por: Pagani, Marco, et al.
Publicado: (2021) -
Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013) -
Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders
por: Trifonova, Ekaterina A., et al.
Publicado: (2022)